Clinical Trials in Neurology
Clinical Trials in Neurology comprehensively tackles the methodology and design of clinical trials in neurological disease. A general section deals with the ethical aspects, drug development and regulatory requirements, basic trial designs and the statistics used. A diseases section tackles specific...
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
London
Springer London
2001, 2001
|
| Edition: | 1st ed. 2001 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- 32 Multiple Sclerosis: Experience with Large Clinical Trials
- 33 Motor Neurone Disease: Ethics, Outcome Variables and Clinical Scales
- 34 Motor Neurone Disease: Basic Designs, Sample Sizes and Pitfalls
- 35 Motor Neurone Disease: Experience with Large Multicentre Trials
- 36 Peripheral Neuropathies: Controlled Clinical Trials
- 37 Peripheral Neuropathies: Experience with Large Multicentre Trials
- 38 Disorders of the Neuromuscular Junction: Outcome Measures and Clinical Scales
- 39 Myasthenia Gravis: Basic Designs, Sample Sizes and Pitfalls
- 40 Myopathies: Ethics, Outcome Variables and Clinical Scales
- 41 Myopathies: Basic Designs, Sample Sizes and Pitfalls
- 18 Clinical Trials in Stroke Prevention in North America
- 19 Cerebrovascular Disease: Experience Within Large Multicentre Trials
- 20 Epilepsy: Ethics, Outcome Variables and Clinical Scales
- 21 Epilepsy: Basic Designs, Sample Sizes and Experience with Large Multicentre Trials
- 22 Headache: Ethics, Outcome Variables and Clinical Studies
- 23 Headache: Basic Trial Designs, Sample Sizes and Pitfalls
- 24 Headache: Experience with Large Multicenter Trials in the Treatment of Migraine Attacks
- 25 Parkinson’s Disease: Outcome Variables and Clinical Scales
- 26 Parkinson’s Disease: A Review of Drug Trials
- 27 Parkinson’s Disease: Experience with Large Multicentre Trials
- 28 Tremor: Clinical Measurement of Impairment, Disability and Handicap
- 29 Tremor: Natural Behaviour, Trial Design and Physiological Outcome Measures
- 30 Multiple Sclerosis: Ethics, Outcome Variables and Clinical Scales
- 31 Multiple Sclerosis: Study Design, Sample Sizes and Pitfalls
- 1 Ethical Considerations
- 2 Assessment Measures and Clinical Scales
- 3 Ethics, Outcome Variables and Clinical Scales: The Clinician’s Point of View
- 4 The Cochrane Collaboration Reviews in Neurology
- 5 Drug Development Stages
- 6 Drug Regulatory Requirements in the United Kingdom and Europe
- 7 Drug Regulatory Requirements in the United States
- 8 Quality Control and Data Monitoring: A Guide To Good Clinical Practice
- 9 Statistical Issues in Clinical Trials in Neurology
- 10 Analysis of Results: Statistical Principles
- 11 Survival Analysis
- 12 The Intention-to-Treat Principle for Clinical Trials
- 13 Statistical Analysis of Repeated-Measures Data with Drop-outs
- 14 The Role of Meta-analyses in Clinical Research: Uses and Limitations
- 15 Outcome Variables in Dementia Trials: Conceptual and Practical Issues
- 16 Dementia: Trial Design and Experience with Large Multicentre Trials
- 17 Cerebrovascular Disease: Basic Designs, Sample Sizes and Pitfalls